Randomised controlled trial of posterior sub-Tenon triamcinolone as adjunct to panretinal photocoagulation for treatment of diabetic retinopathy
- Dr K Nishijima, Department of Ophthalmology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan; nissi{at}kuhp.kyoto-u.ac.jp
- Accepted 20 January 2009
- Published Online First 12 February 2009
Abstract
Aims: To evaluate the efficacy of a single posterior sub-Tenon capsule injection of triamcinolone acetonide (PSTA) before panretinal photocoagulation (PRP).
Methods: This 6-month study involved the randomisation of 82 eyes of 41 patients, with bilateral severe non-proliferative diabetic retinopathy or proliferative diabetic retinopathy to a single PSTA 20 mg or to no injection before PRP. The primary end-point was change in best-corrected visual acuity (BCVA) at 6 months compared with that at baseline using the logarithm of the minimum angle of resolution (logMAR). Secondary end-points were changes in retinal thickness and intraocular pressure.
Results: The mean changes in logMAR BCVA at 6 months compared with that at baseline were a worsening of 0.010 (SD 0.029) in the control group (no injection) and an improvement of 0.072 (0.028) in the PSTA group (p = 0.04). The mean changes in foveal thickness at 6 months compared with baseline measurements were an increase of 32.8 (82.8) μm in the control group and a lessening of 9.7 (85.6) μm in the PSTA group (p = 0.03).
Conclusions: PSTA before PRP appears to be beneficial in preventing PRP-induced visual loss in eyes with diabetic retinopathy by reducing the chance of macular thickening.
Footnotes
-
Competing interests: None.
-
Funding: Supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of the Japanese government.
-
Ethics approval: Ethics approval was provided by the Ethics Committee at Kyoto University.
-
Patient consent: Obtained.
-
▸ A supplemental figure is published online only at http://bjo.bmj.com/content/vol93/issue6







